Key result
CCT matches CMR in identifying late enhancement and elevated ECV in cancer therapy-related cardiac dysfunction.
Why the study?
CMR is the gold standard for diagnosing CTRCD, but the consistency of CCT with CMR imaging in CTRCD cases required investigation.
Does cardiac computed tomography (CCT) provide consistent diagnostic information compared to cardiac magnetic resonance (CMR) imaging in patients with cancer therapy-related cardiac dysfunction (CTRCD)?
Observational (n=7)
No
Does cardiac computed tomography (CCT) provide consistent diagnostic information compared to cardiac magnetic resonance (CMR) imaging in patients with cancer therapy-related cardiac dysfunction (CTRCD)?
Answers are grounded in this paper and cite their sources.
Cardiac computed tomography provides consistent information on late myocardial enhancement and extracellular volume quantification compared to cardiac magnetic resonance in patients with cancer therapy-related cardiac dysfunction.
BACKGROUND: Cardiac magnetic resonance (CMR) imaging is the golden standard used for the diagnosis of cancer therapy-related cardiac dysfunction (CTRCD). The consistency of cardiac computed tomography (CCT) in CTRCD cases using CMR imaging is investigated in this study. METHODS AND RESULTS: In 7 clinically confirmed CTRCD patients, focal late enhancement was confirmed on both CCT and CMR for 4 patients. Myocardial extracellular volume (ECV) values measured by CCT and CMR were elevated in all patients, suggesting the presence of diffuse myocardial damage. CONCLUSIONS: The study findings indicated that CCT could provide adequate information about late myocardial enhancement and ECV quantification, indicating the effective evaluation of CTRCD by CCT.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted an observational in Cancer therapy-related cardiac dysfunction (CTRCD) (n=7). Cardiac computed tomography (CCT) vs. Cardiac magnetic resonance (CMR) was evaluated on Consistency of late enhancement and extracellular volume (ECV) quantification between CCT and CMR. Cardiac computed tomography demonstrated consistency with cardiac magnetic resonance imaging in identifying focal late enhancement and elevated extracellular volume in patients with cancer therapy-related cardiac dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: